The forecasted mortality rates for trachea, bronchus, or lung malignant neoplasms in the UK among females show a consistent decline from 2024 through 2028. The rate decreases from 35.0 in 2024 to 31.7 in 2028, indicating a significant downward trend in female deaths per hundred thousand women due to these causes. Year-on-year reductions are around 2.5%, reflecting advancements in healthcare interventions and prevention strategies. The Compound Annual Growth Rate (CAGR) over the five-year period averages at a decline of approximately 2.5%.
- Declining mortality trends suggest improvements in treatment and early detection.
- Future trends to watch include developments in personalized medicine, advances in non-invasive screening methods, and public health interventions targeting smoking cessation and air quality improvements, which are likely to further decrease the mortality rates.
